Madhvi Rajpurkar
Pediatrics · Detroit, MINPI 1336186824
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $145,788 of the $162,393 with a category attached, or 89.8%. 17 manufacturers reported payments, led by Novo Nordisk at 38.5% of the total. 2025 is the largest year on record at $48,582, 2.1 times the $22,798 reported in 2019. Among pediatrics clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $1640.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$63K
- Novo Nordisk AS$32K
- Sanofi$23K
- Sanofi US Services Inc.$14K
- Shire North American Group Inc$10K
- Takeda Pharmaceuticals U.S.A., Inc.$9K
- plus $12K from 11 others
Across 41 payments — averaging $4342.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$94K
- Genentech, Inc.$44K
- Takeda Pharmaceuticals U.S.A., Inc.$16K
- Pfizer$10K
- Novo Nordisk$9K
- Diagnostica Stago, Inc$6K
What the payments were for
- Consulting fees$145,78890%
- Speaking & faculty fees$6,0994%
- Travel & lodging$7,6715%
- Food & beverage$2,7432%
- Education$930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $62,542 |
| Novo Nordisk AS | 6 | $31,705 |
| Sanofi | 15 | $23,229 |
| Sanofi US Services Inc. | 1 | $13,598 |
| Shire North American Group Inc | 19 | $10,177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $9,140 |
| Sobi, Inc | 8 | $7,275 |
| Spark Therapeutics, Inc. | 2 | $4,246 |
| Penumbra, Inc. | 1 | $161 |
| Octapharma USA, Inc. | 2 | $107 |
| CSL Behring | 1 | $60 |
| Jazz Pharmaceuticals Inc. | 1 | $33 |
| Caris MPI, Inc. | 1 | $33 |
| Pfizer | 2 | $28 |
| Agios Pharmaceuticals, Inc. | 1 | $28 |
| Medunik USA Inc. | 1 | $19 |
| Coloplast | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QFITLIA$12,747
- ADVATE$12,499
- ALTUVIIIO$10,206
- NovoSeven RT$9,180
- NovoSeven$7,560
- DOPTELET$7,129
- Indigo System$161
How this compares
$162,393 in reported general payments places this provider in the 95th percentile of 1,473 pediatrics providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Detroit
- Meera ChitlurDetroit$236K
- Wanda Whitten-ShurneyDetroit$152K
- Marcus DegrawDetroit$62K
- Nedim CakanDetroit$55K
- Norris PolkDetroit$32K
- Lynn SmithermanDetroit$25K
- Yaddanapudi RavindranathDetroit$11K
- Esperanza Font-MontgomeryDetroit$5K
- Itemad BadrDetroit$5K
- Deepa Soundara RajanDetroit$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.